NCT01177254已完成不适用
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10,000
研究概览
简要总结
Using a retrospective analysis of a large commercial claims database and a Medicare database, the investigators evaluated DDEs that have the potential to cause DDIs among chronic low back pain (cLBP) patients on long-term opioid analgesia, which metabolizes through the CYP450 enzyme system, concomitant with other CYP450-metabolized drug(s).
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •chronic low back pain
排除标准
- •pregnancy
研究者
Joseph Pergolizzi, MD
Principal Investigator
NEMA Research, Inc.
相似试验
已完成
不适用
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking OpioidsChronic Low Back PainNCT01177241NEMA Research, Inc.10,000
已完成
不适用
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions(DDI) Among Osteoarthritis PatientsOsteoarthritisNCT01177267NEMA Research, Inc.10,000
已完成
1 期
A Study to Assess the Effects of Itraconazole and Rifampin on Lazertinib in Healthy Adult ParticipantsHealthyNCT04410094Janssen Research & Development, LLC32
已完成
4 期
Pharmacogenetic and Pharmacokinetics of Naproxen and Associated Naproxen-esomeprazolePoor Metabolizer Due to Cytochrome P450 CYP2C9 VariantPoor Metabolizer Due to Cytochrome p450 CYP2C19 VariantNCT03092193University of Sao Paulo8
Unknown
不适用
VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin ManagementCardiac ThrombusDeep Vein ThrombosisHeart Valve Replacement (Mechanical or Biological With AF)Cardiomyopathy (Ischemic or Dilated)Atrial FibrillationPeripheral Vascular DiseasePulmonary EmbolismNCT00970892Ankara University500